Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of musculoskeletal disorders and rheumatic diseases in an Argentinean indigenous Wichi community.
Juárez V, Quintana R, Crespo ME, Aciar M, Buschiazzo E, Cucchiaro NL, Picco E, Ruiz M, Sánchez JA, Franco R, Estrella N, Jorge S, Retamozo C, Silvestre AMR, García V, Pelaez-Ballestas I, Pons Estel BA. Juárez V, et al. Among authors: sanchez ja. Clin Rheumatol. 2021 Jan;40(1):75-83. doi: 10.1007/s10067-020-05130-3. Epub 2020 Jun 5. Clin Rheumatol. 2021. PMID: 32504194
Inequity and vulnerability in Latin American Indigenous and non-Indigenous populations with rheumatic diseases: a syndemic approach.
Granados Y, Gastelum Strozzi A, Alvarez-Nemegyei J, Quintana R, Julian-Santiago F, Santos AM, Guevara-Pacheco S, Loyola-Sanchez A, Goycochea-Robles MV, Juarez V, Garza-Elizondo MA, Rueda JC, Burgos-Vargas R, Londoño J, Pons-Estel BA, Pelaez-Ballestas I; Latin American Study Group of Rheumatic Diseases in Indigenous Peoples (GLADERPO); GLADERPO. Granados Y, et al. BMJ Open. 2023 Mar 23;13(3):e069246. doi: 10.1136/bmjopen-2022-069246. BMJ Open. 2023. PMID: 36958782 Free PMC article.
Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
Papais-Alvarenga RM, Vasconcelos CC, Carra A, de Castillo IS, Florentin S, Diaz de Bedoya FH, Mandler R, de Siervi LC, Pimentel ML, Alvarenga MP, Alvarenga MP, Grzesiuk AK, Gama Pereira AB, Gomes Neto AP, Velasquez C, Soublette C, Fleitas CV, Diniz DS, Armas E, Batista E, Hernandez F, Pereira FF, Siqueira HH, Cabeça H, Sanchez J, Brooks JB, Gonçalves MV, Barroso MC, Ravelo ME, Castillo MC, Ferreira ML, Rocha MS, Parolin MK, Molina O, Marinho PB, Christo PP, Brant de Souza R, Pessanha Neto S, Camargo SM, Machado SC, Neri VC, Fragoso YD, Alvarenga H, Thuler LC. Papais-Alvarenga RM, et al. PLoS One. 2015 Jul 29;10(7):e0127757. doi: 10.1371/journal.pone.0127757. eCollection 2015. PLoS One. 2015. PMID: 26222205 Free PMC article. Clinical Trial.
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, Vu TQ, Antonuzzo L, Wiechno P, Atduev V, Kann AG, Kim TH, Suárez C, Chang CH, Roghmann F, Özgüroğlu M, Eigl BJ, Oliveira N, Buchler T, Gadot M, Zakharia Y, Armstrong J, Gupta A, Hois S, van der Heijden MS; NIAGARA Investigators. Powles T, et al. N Engl J Med. 2024 Nov 14;391(19):1773-1786. doi: 10.1056/NEJMoa2408154. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282910 Clinical Trial.
Reliability of Magseed® marking before neoadjuvant systemic therapy with subsequent contrast-enhanced mammography in patients with non-palpable breast cancer lesions after treatment: the MAGMA study.
Bravo EI, Martínez AM, Alvà HP, Sancho DR, López JCA, Sánchez JA, Casa PE, de Las Heras CG, Venegas MAF, Vidal EG, Begines ED, Mur CG, Vicente I, Casamayor C, Cruz S, Barrado AG. Bravo EI, et al. Among authors: sanchez ja. Breast Cancer Res Treat. 2024 Nov;208(1):133-143. doi: 10.1007/s10549-024-07407-6. Epub 2024 Jun 20. Breast Cancer Res Treat. 2024. PMID: 38898360 Free PMC article.
485 results